RECURRENT VULVOVAGINAL CANDIDIASIS
Clinical trials for RECURRENT VULVOVAGINAL CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVOVAGINAL CANDIDIASIS trials appear
Sign up with your email to follow new studies for RECURRENT VULVOVAGINAL CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in stopping yeast infections from coming back
Disease control CompletedThis study tested whether a medication called oteseconazole could prevent recurrent yeast infections in women who experience them frequently. 438 women who had at least 3 yeast infections in the past year took either the study pill or a placebo (dummy pill) for 12 weeks, then wer…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:04 UTC
-
Breakthrough pill tested to stop yeast infections from coming back
Disease control CompletedThis study tested whether a new oral medication called oteseconazole could safely prevent recurrent yeast infections in women. Over 400 women who typically had at least three infections a year were randomly assigned to take either the new drug or a placebo pill for 12 weeks, then…
Matched conditions: RECURRENT VULVOVAGINAL CANDIDIASIS
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 13, 2026 20:22 UTC